Suppr超能文献

印度疼痛研究协会癌症疼痛特别兴趣小组癌症疼痛药物治疗指南(第三部分)

Indian Society for Study of Pain, Cancer Pain Special Interest Group Guidelines on Pharmacological Management of Cancer Pain (Part III).

作者信息

Ramanjulu Raghavendra, Thota Raghu S, Ahmed Arif, Jain Parmanand, Bhatnagar Sushma, Salins Naveen, Chatterjee Aparna, Bhattacharya Dipasri

机构信息

Department of Pain and Palliative Care, Cytecare Hospital, Bengaluru, Karnataka, India.

Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

出版信息

Indian J Palliat Care. 2020 Apr-Jun;26(2):191-197. doi: 10.4103/0973-1075.285694.

Abstract

The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care members. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on the use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus it is not recommended.

摘要

印度疼痛研究协会(ISSP)癌症疼痛特别兴趣小组发布的成人癌症疼痛药物治疗指南提供了一种结构化的、循序渐进的方法,这将有助于改善癌症疼痛的管理,并为患者提供最低可接受的生活质量。这些指南是根据现有文献和证据制定的,以适应印度的需求、患者群体和情况。基于每个子草案的关键要素制作了一份问卷,用于解决某些缺乏证据的不确定领域,并在ISSP网站上发布,并通过电子邮件分发给所有ISSP成员和印度姑息治疗协会成员。应使用抗抑郁药和/或抗惊厥药治疗神经性癌症疼痛,剂量应根据临床反应和副作用进行滴定。所有有疼痛性转移性骨痛的患者均应接受外照射放疗。有证据表明氯胺酮可用于癌症神经性疼痛,但无有益效果,因此不推荐使用。

相似文献

6
8

引用本文的文献

1
Amitriptyline nanoparticle repositioning prolongs the anti-allodynic effect of enhanced microglia targeting.
Nanomedicine (Lond). 2024;19(25):2099-2112. doi: 10.1080/17435889.2024.2390349. Epub 2024 Sep 4.
2
Neuropathic Pain in Cancer: What Are the Current Guidelines?
Curr Treat Options Oncol. 2024 Sep;25(9):1193-1202. doi: 10.1007/s11864-024-01248-7. Epub 2024 Aug 5.

本文引用的文献

1
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines.
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv166-iv191. doi: 10.1093/annonc/mdy152.
2
Side effects of corticosteroids in patients with advanced cancer: a systematic review.
Support Care Cancer. 2018 Dec;26(12):3979-3983. doi: 10.1007/s00520-018-4339-2. Epub 2018 Jul 6.
3
Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial.
JAMA Oncol. 2018 Jun 1;4(6):870-872. doi: 10.1001/jamaoncol.2018.0131.
4
Ketamine as an adjuvant to opioids for cancer pain.
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD003351. doi: 10.1002/14651858.CD003351.pub3.
5
WITHDRAWN: Radioisotopes for metastatic bone pain.
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD003347. doi: 10.1002/14651858.CD003347.pub3.
6
Ketamine for cancer pain: what is the evidence?
Curr Opin Support Palliat Care. 2017 Jun;11(2):88-92. doi: 10.1097/SPC.0000000000000262.
9
Corticosteroids for the management of cancer-related pain in adults.
Cochrane Database Syst Rev. 2015 Apr 24;2015(4):CD010756. doi: 10.1002/14651858.CD010756.pub2.
10
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Epub 2015 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验